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Introduction  
INTRODUCTION 
 Acquired immunodeficiency syndrome (AIDS) was recognized 
as a new disease for the first time in 1981.
1 
AIDS was recognized because in 
March 1981 eight cases of more aggressive form of  Kaposi’s Sarcoma had 
occurred amongst young gay men in New York and at the same time there 
was an increase in the number of cases of Pneumocystis Carinii pneumonia 
(PCP) in both California and New York.
2, 3 
Despite the development of 
laboratory methods, dermatological symptoms were in the past and still are 
the basic indicators of presence and physical course of the disease; human 
immunodeficiency virus (HIV) infection and AIDS are frequently related to 
a wide range of skin and mucosal manifestations.
1
 This ranges from macular, 
roseola like rash in the  acute seroconversion  syndrome to the extensive 
end-stage Kaposi’s Sarcoma.
4  
 
 In primary HIV infection manifestations like fever, joint pain and 
night sweats are non specific for identifying acute seroconversion, because 
in developing countries where other endemic diseases with similar 
complaints are common.
5, 6  
In the developed countries, primary HIV-1 
infection is estimated to be symptomatic in up to 80% of cases [Acute 
retroviral syndrome (ARS)] 
7 
with the advent of Highly Active Anti 
Retroviral Therapy, the course of HIV/AIDS has been significantly changed. 
 In this study an attempt is made to find out the various dermatological 
manifestations associated with HIV/AIDS and to identify the most common 
predictor of HIV/AIDS in this part of the country. 
  
 
 
 
 
 
 Literature Review         
LITERATURE REVIEW 
 
Epidemiology of HIV/ADIS: 
 Ever since its recognition in 1981, HIV/ADIS Continues to ravage all 
the continents of the world.
8 
More than 25 million people have died of AIDS 
since 1981.
9 
 
World Wide Statistics: 
 At the end of 2008, women accounted for 50% of all adults living 
with HIV worldwide.
 
Africa has over 14 million AIDS orphans.
 
The number 
of people living with HIV has risen from around 8 million in 1990 to 33 
million today, and is still growing. Around 67% of people living with 
HIV/AIDS are in Sub Saharan Africa. In developing and transitional 
countries, 9.5 million people are in immediate need of life saving AIDS 
drugs; of these only 4 million (42%) are receiving the drugs.
9
  
 
 
 
TABLE 1 
Worldwide statistics of people living with HIV/AIDS 
People Living with HIV/AIDS 
 in 2008 
Estimate (million) 
Adults 31.3 
Women 15.7 
Children 2.1 
 
TABLE 2 
 World HIV/AIDS statistics 
 
 
 
 
European HIV and AIDS statistics: 
 According to UNAIDS estimates, around 2.3 million people were 
living with HIV in Europe at the end of 2008.
10
 The number of AIDS cases 
per million populations has declined slightly in western and central Europe, 
as a result of the widespread availability of antiretroviral drugs in this 
region.
11 
 
South Africa National HIV survey 2008: 
 10.9% of all South Africans over 2 years old were living with HIV in 
2008. Among females, HIV prevalence is highest in those between 25 and 
29 years old; among males, the peak is in the group aged 30-34 years
12
. 
Antenatal surveillance is internationally recognized as the most useful way 
of assessing HIV prevalence among women aged 15-19 years old, for which 
the antenatal survey produce a rate much higher than the household survey 
(15.9% compared to 9.4%).
13 
 
Sub-Saharan Africa HIV and AIDS Statistics: 
 An estimated 22.4 million adults and children were living with HIV in 
Sub-Saharan Africa at the end of 2008. During that year an estimated 1.4 
million Africans died from AIDS. Around 14.1 million children have lost 
one or both parents in the epidemic, and in 2008 an estimated 1.8 million 
children were living with HIV.
14
 
India HIV and AIDS statistics: 
India has a population of one billion, around half of whom are adults 
in the sexually active age group. The first AIDS case in India was detected 
in 1986
15
, and since then HIV infection has been reported in all states and 
union territories. The highest HIV prevalence rates are found in Andra 
Pradesh, Maharashtra, Tamil Nadu and Karnataka in the south and Manipur 
and Nagaland in the North-East. In the south states, HIV is primarily spread 
through heterosexual contacts. Infections in north-east are mainly found 
among injecting drug users (IDUs) and sex workers
16
. The average HIV 
prevalence among women attending antenatal clinics in India is 0.48% much 
higher rates found among people attending STD clinics, female sex workers 
(5.1%), Injecting drug users (7.2%) and men who have sex with men 
(7.4%)
17 
 
 Antiretroviral drugs (ARVs) which can significantly delay the 
progression from HIV to AIDS have been available in developed countries 
since 1996. In India an estimated 300,000 people were receiving free AVRs 
by January 2010. This represents less than half of those estimated to be in 
antiretroviral treatment in India.
18
 
 
 
 
HIV TRANSMISSION 
 
The primary routes of transmission are through sexual intercourse, 
vertically from mother to infant during pregnancy or early infancy, 
percutaneous exposure and exposure to infected blood and its products
29
. 
 
SEXUAL TRANSMISSION: 
  Sexual transmission of HIV infection can occur following vaginal 
and anal intercourse, and also through oral sex. Male to female HIV 
transmission is twice as effective as female to male transmission
19
.  The risk 
of male to female of HIV transmission during a single genital exposure has 
been calculated as less than 0.2%
20
. 
 
The risk of male to male transmission 
per episode of unprotected anal intercourse has been estimated to between 
0.3% and 10%.
21 
 
MOTHER TO CHILD TRANSMISSION (MTCT) 
  HIV infection from an HIV positive  mother to her child can occur 
during pregnancy, delivery or breast feeding
22
. 
 Without treatment around 15-30% of babies born to HIV positive 
women become infected with HIV during pregnancy and delivery
23
. A 
further 5-20% becomes infected through breast feeding
24
. In 2009, an 
estimated 4, 30,000 children become newly infected with, the majority of 
them through MTCT.
 22
 
 The risk associated with prenatal transmission of HIV–1 are 
multifactorial. Known risk factor include high maternal plasma viremia, 
advanced clinical HIV–1 diseases, reduced maternal immunocompetence, 
vaginal delivery and a lengthy interval between rupture of the amniotic 
membrane and delivery.
 23
 In addition, exposure to maternal blood, presence 
of ulcerative genital infection in maternal vaginal track at the time of 
delivery, illicit drug use during pregnancy, prematurity and low birth weight 
have all been associated with increased mother to child transmission.
25 
 There is evidence suggesting that pregnancy also favours the 
progression of the HIV disease in the mother. The most important 
determinant is the viral load present in the mother.
26 
 
BLOOD – BORN TRANISMISSION OF HIV: 
 There is approximately a 90% risk of transmission of HIV to a 
recipient if the blood is donated during the window period. Donor screening 
and HIV testing of donors can prevent HIV transmission through blood and 
blood products. 
29 
 
OCCUPATIONAL EXPOSURE: 
 The risk of HIV infection from a single percutaneous exposure is 
estimated to be approximately0.3%. The risk of transmission following 
exposure to intact mucosa and skin is postulated to be considerably less.
27 
 
ORGAN AND TISSUE DONATION: 
 HIV transmission can occur following the transplantation of human 
organs or following bone marrow transplantation from infected donors.
28
     
 
STAGES OF HIV INFECTION: 
 The HIV infected person will progress more or less sequentially 
through a series of characteristic clinical stages with the progressive 
depletion of CD4+ lymphocytes counts.
30
 
The HIV Infection can be divided into four stages 
1. Acute seroconversion illness or primary HIV infection 
2. Asymptomatic stage of HIV infection 
3. Late symptomatic stage of HIV infection. 
4. Late Symptomatic and advanced stage of HIV infection (AIDS) 
 
STAGE 1: PRIMARY HIV INFECTION 
 Primary infection is also called the seroconversion illness or acute 
HIV infection.
30
 However 30% - 50% of individuals present with 
mononucleosis like illness within 2 -6 week of exposure,
31
 resolves within 2 
weeks. Transient CD4+ lymphopaenia has been seen in the few patients 
studies.
32
 It has been observed that a longer duration of symptomatic 
seroconversion is associated with more rapid progression of the disease.
33, 34
 
This being a stage of acute viremia, high levels of circulating free virions 
can be detected by RT- PCR.
34
 The tests for HIV antibodies are negative in 
this stage.
30
 A seroconversion illness associated with HIV – 2 infections has 
been reported.
35 
  
STAGE 2: ASYMPTOMATIC STAGE OF HIV INFECTION:  
 Duration varies from 6 months to 15 years. 
31
 
 During this stage patient is asymptomatic and generally has no 
findings on physical examination excerpt for persistent generalized 
lymphadenopathy (PGL) in some cases.
36
 Occasionally people may 
experience headaches, which can be recurrent or chronic debilitating in 
nature.
37  
The rate of decline of the CD4 cell count has been estimated as 84 
cells per year for the first 4 years after seroconversion.
38 
 
STAGE 3: EARLY SYMPTOMATIC STAGE OF HIV INFECTION: 
 Using statistical models, it has been projected that 76% of HIV 
infected people will develop late symptomatic diseases by the year 16 of 
infection.
39
 The rate of HIV 1 disease progression has been estimated to be 3 
to 4 times greater than that of HIV 2.
40
 Though in the early stage of HIV 
disease, the levels of virus detectable in the peripheral blood often remain 
low.
30
 However this masks every rapid rate of virus production and 
destruction in lymphoid tissue.
41 
 
Anergy to skin testing increases as the CD4+ count falls below 400/µl 
with obvious implications for tuberculosis screening. 
30
 Common episodic 
conditions during this stage of disease include Herpes zoster, Candidiasis, 
Seborrhoeic dermatitis, skin and nail infections like impetigo, folliculitis, 
fungal intertrigo and paronychia along with bacterial infection like 
pneumonia, bronchitis and sinusitis.
30 
 
 Recurrent Herpes zoster is one of the earliest manifestation of 
symptomatic disease. Oral candidiasis and Oral hairy leukoplakia (OHL) 
also occur in Stage 3 of HIV
30
. In one study of cohorts of homosexual men, 
the 2 years progression of AIDS for men with Herpes zoster, Candidiasis, 
Oral hairy leukoplakia and constitutional symptoms were 25%, 39%, 42% 
and 100% respectively.
42 
 
 
STAGE 4: LATE SYMPTOMATIC AND ADVANCED STAGES OF 
HIV INFECTION (AIDS) 
 
 In the absence of treatment the HIV infection progress and the 
manifestation of late symptomatic disease typically appears in CD4+ count 
fall below 200/µl. In the absence of prophylaxis, Pneumocystis carinii, 
pneumonia (PCP) is the most common and life threatening infection
30
. 
 
 Crowe found that the order of appearance of opportunistic infection 
and malignancies during this stage was strongly correlated with the CD4+ 
lymphocyte count
43
.   
  In advanced stage of HIV disease, where CD4+ cell counts have fallen 
below 50/µl, chorioretinits, mycobacterium avium complex (MAC) and 
primary cerebral lymphoma may occur and HIV-1 associated dementia 
appears to progress more rapidly. Infections such as MAC, CMV, 
strongyloides stercoralis, herpes zoster or tuberculosis, that normally 
colonise superficially or are limited to an organ system or a local anatomic 
region, may invade other tissue or disseminate widely
30
. Several of these 
opportunistic diseases have been described in HIV- 2 infected individuals. 
 
MUCO CUTANEOUS MANIFESTATIONS OF HIV INFECTION: 
 Dermatological manifestations are seen at every stage of HIV 
infection and are often its presenting features
44
. The most common 
mucocutaneous lesions are oro-esophageal candidiasis, oral hairy 
leukoplakia, Kaposi’s sarcoma, histoplasmosis, and, in Asia, Penicillium 
marneffei infection. Non-HIV-related skin lesions, such as psoriasis, 
seborrhoeic dermatitis, and nodular prurigo, may be the initial presentation 
among HIV infected patients attending outpatient clinics.
45 
PATHOGENESIS  
 
 Since HIV is not eliminated after primary infection, persistent virus 
replication occurs in lymphoid organs during the course of HIV infection.
46
 
Destruction of lymphoid tissue results in severe impairment of the ability to 
maintain an effective on going HIV specific immune response and to 
generate immune response against new pathogens.
47
 Epidermal Langerhans 
cells may become infected by HIV, and decreased Langerhans cell function 
could account for some of the cutaneous manifestations of HIV disease.
46
 
 
CUTANEOUS MANIFESTATIONS OF HIV 
CLASSIFICATION OF DERMATOSES IN HIV /AIDS: 
FUNGAL INFECTIONS 
Candidiasis 
Pityrosporum infection 
Dermatophytosis  
Cryptococcosis 
 Histoplasmosis 
 Penicilliosis 
Aspergillosis. 
 
VIRAL INFECTIONS 
Herpes simplex infection 
Varicella zoster infection 
Epstein Barr virus infection 
Cytomegalovirus infection 
Human papilloma virus infection 
Molluscum contagiosum  
Hepatitis B and hepatitis C virus Infection 
 
BACTERIAL INFECTIONS 
Staphylococcal infections   
Mycobacterial infections   
Bacillary angiomatosis   
 Lymphogranuloma venereum  
 Syphilis 
 Chancroid 
PARASITIC INFECTIONS 
Scabies   
Demodicidosis   
 INFLAMMATORY DISODERS 
 Seborrhoeic dermatitis 
 Psoriasis 
 Reiter’s disease 
 Ichthyosiform dermatoses. 
Papular and follicular eruption of HIV   
Drug reaction 
 
NEOPLASIA  
Kaposi sarcoma  
Lymphoma  
Other cutaneous carcinomas 
 
MISCELLANEOUS DERMATOSES 
Hidradenitis suppurativa 
Generalized hyper pigmentation 
Insect bite reactions --- increased 
Photosensitive eruptions 
 
HAIR CHANGES 
 
NAIL CHANGES
CLASSIFICATION OF DERMATOSES IN HIV/ AIDS: 
FUNGAL INFECTIONS 
Candidiasis 
Candidiasis or thrush is a fungal infection (mycosis) of any of the 
Candida species (all yeasts), of which Candida albicans is the most 
common.
48, 49 
Mucocutaneous candidiasis occurs in 3 forms in persons with 
HIV infection: oropharyngeal, esophageal, and vulvovaginal disease. 
Oropharyngeal candidiasis (OPC) was among the initial manifestations of 
HIV-induced immunodeficiency to be recognized
50,51 
and typically affects 
the majority of persons with advanced untreated HIV infection. Presenting 
months or years before more severe opportunistic illnesses, OPC may be a 
sentinel event indicating the presence or progression of HIV disease.
52,53,54 
Although usually not associated with severe morbidity, OPC can be 
clinically significant. Severe OPC can interfere with the administration of 
medications and adequate nutritional intake, and may spread to the 
esophagus.
55
 Esophageal candidiasis remains one of the most common 
opportunistic infections in countries where combination antiretroviral 
therapy (ART) is a routine part of the standard of care.
56 
Vulvovaginal 
candidiasis is an important concern for women with HIV infection, although 
the relationship of vulvovaginal candidiasis to HIV infection remains 
unclear.
57
 In resource-poor nations, mucocutaneous candidiasis is a 
formidable problem.
58,59
 Despite the frequency of mucosal disease, 
disseminated or invasive infections with Candida and related yeasts are 
surprisingly uncommon. 
 
Pityrosporum infection 
Malassezia furfur has been linked to several skin diseases, including 
seborrhoeic dermatitis, folliculitis, pityriasis versicolor, and atopic 
dermatitis.
60 
Seborrheic dermatitis is one of the earliest clinical markers of 
HIV infection.
47
 Pityrosporum folliculitis (PF) is an inflammatory skin 
disorder that typically manifests as a pruritic, follicular papulopustular 
eruption distributed on the upper trunk of young to middle-aged adults. 
Weary et al first described Pityrosporum folliculitis in 1969, and, later in 
1973.
61
 Pityrosporum folliculitis is present on body locations in which 
Malassezia organisms are most abundant: back and chest, neck, shoulders, 
scalp.
62 
 
Dermatophytosis  
The dermatophyte infections that HIV-infected patients develop tend 
to be more severe, atypical and refractory to treatment.
63
 Normally, these 
fungal infections remain superficial in the epidermis, but in HIV patients the 
infection can become invasive. The most common presentation of deep or 
locally invasive fungal infection is the eruption of nodules near the initial 
site of infection, but abscesses, mycetomas and atypical lesions are also 
possible. T. rubrum is most often the cause of this deeper infections.
64 
 Cryptococcosis 
Cryptococcus neoformans is abundant in soil contaminated by pigeon 
droppings. Cryptococcosis is the most common cause of HIV-related 
meningitis in Central and Southern Africa, accounting for up to 40% of 
cases.
65
 Pulmonary cryptococcosis is also being increasingly recognized 
with one study reporting 7% prevalence in a group of South African miners 
(HIV prevalence of 24%).
66
 Secondary cutaneous infections occur in up to 
15% of patients with disseminated cryptococcosis and often indicate a poor 
prognosis. Lesions usually begin as small papules that subsequently ulcerate, 
but may also present as abscesses, erythematous nodules, or cellulitis.
67 
 
Histoplasmosis 
 Histoplasmosis is the most common of the endemic mycoses in 
patients with AIDS.
68
 Disseminated histoplasmosis (DH) initially was 
reported in patients with AIDS in 1982.
69 
In patients with advanced HIV 
infection, histoplasmosis almost always is manifested by signs of 
progressive disseminated disease, as opposed to the asymptomatic or limited 
pulmonary infection observed in the majority of healthy individuals exposed 
to H.capsulatum.
70
 Histoplasmosis is common among AIDS patients 
because of their depressed immune system.
71
 Skin manifestations are 
protean, ranging from papules to ulcers to erythema multiforme.
72 
 
Penicilliosis 
 Penicilliosis is an infection caused by Penicillium marneffei, a 
dimorphic fungus endemic to Southeast Asia and the southern part of 
China.
73 
Persons affected by penicilliosis usually have AIDS with low CD4+ 
lymphocyte count, typically <100 cells/µL. The average CD4+ count at 
presentation is 63.5 cells/µL.
74, 75 
The most common presentation is 
disseminated infection manifested by fever, skin lesions, anemia, 
generalized lymphadenopathy, and hepatomegaly.
74
 Patients with 
penicilliosis have a poor prognosis without treatment.
74
 Skin lesions are 
present in approximately two third of cases and can be varied in appearance. 
Generalized papular eruptions, central umbilicated papules resembling those 
of molluscum contagiosum, acne like lesions and folliculitis all may occur. 
Skin lesions commonly occur on the face, trunk, and extremities. Pharyngeal 
and palatal lesions also can be seen.
76
 Subcutaneous nodules occasionally 
can be seen.
74 
 
Aspergillosis 
Cutaneous Aspergillosis can occur as primary or secondary infection. 
Primary cutaneous aspergillosis is associated with local skin injury (from 
tape, intravenous catheter sites) and neutropenia. Lesions can appear as 
erythematous indurations with overlying pustules, hemorrhagic ulcers, or 
molluscum contagiosum-like lesions. Despite the severe immunosuppression 
that results from advanced HIV infection, there are relatively few cases of 
aspergillosis in patients with HIV disease.
77
  
 
VIRAL INFECTIONS 
Herpes Simplex Infection 
Among HIV-1 infected individuals, HSV-1 and HSV-2 infections are 
common. In recent years, a number of studies have focused on the 
prevalence of HSV-2 among HIV-1 infected individuals, finding 
seroprevalence of 50-90% in some populations, significantly higher than 
among those without HIV-1.
78
 HIV-1-infected persons, however, also can 
have frequent or persistent HSV lesions, often with extensive or deep 
ulcerations, particularly among those with low CD4+ count. In one study, 
the frequency of genital ulcer disease consistent with reactivation of genital 
herpes was found to increase in a stepwise fashion with declining CD4+ 
count.
79
 Among HIV-1-infected persons, HSV mucosal shedding occurs 
more frequently, and with higher quantity of HSV, among those with lower 
CD4+ counts.
80, 81, 82
 
 
Varicella Zoster Infection 
Varicella zoster virus (VZV) infection is commonly seen early in the 
course of HIV infection, particularly in healthy-appearing individuals, 
before the onset of other symptoms.
83,84,85,86,87
 Because most HIV-infected 
persons have had varicella previously, the initial manifestation of VZV 
infection is usually Herpes zoster. During the course of HIV disease, herpes 
zoster often precedes thrush and oral hairy leukoplakia by about one year.
85
 
Unlike zoster in individuals without HIV infection, this dermatomal eruption 
may be particularly bullous, hemorrhagic, necrotic, and painful in HIV-
infected persons. The duration of blisters and crusts is usually 2 or 3 weeks. 
The approximate duration of significant pain is also 2 or 3 weeks. Necrotic 
lesions may last for up to 6 weeks and heal with severe scarring. This 
dermatomal scarring is characteristic of HIV-infected patients and should be 
sought when evaluating at-risk individuals.
88
 Recurrences have been 
reported in up to 25% of African HIV-infected persons with herpes zoster.
86
 
 
Epstein Barr Virus Infection 
          It is a gamma herpesvirus, also called human herpesvirus 4.
89,90
 Oral 
hairy leukoplakia is a hyperplastic EBV-induced mucocutaneous epithelial 
cell disease and the first pathologic manifestation attributable to replicative 
EBV infection,
 91
 making the lesion unique in EBV biology. It is seen in up 
to 25% of homosexual men with AIDS but has been reported as well in other 
immunocompromised patients and, rarely, healthy individuals.
91, 92 
 
Cytomegalovirus Infection 
In humans it is commonly known as Human Herpesvirus
93
. Most 
healthy people who are infected by CMV after birth have no symptoms.
93
 
Some of them develop an infectious mononucleosis/glandular fever-like 
syndrome
94
. 
 
Human Papilloma Virus Infection 
Superficial cutaneous infection with human papilloma virus (HPV) or 
warts, occurs with increased frequency in immunosuppressed patients. 
Lesions may be extensive and resistant to therapy. Condyloma acuminata are 
of special significance in persons with HIV infection. Cervical dysplasia and 
carcinoma are clearly associated with HPV infection.
95
 Unfortunately, 
anorectal warts in HIV-infected men are difficult to eradicate.
96 
Female HIV-
infected patients must have regular gynaecological examinations and 
Papanicolaou (Pap) smears.
97, 98
 
 
Molluscum Contagiosum  
Molluscum Contagiosum is characterised by a faint whitish core at the 
center of each papule, some of which may be slightly umbilicated. 
 Molluscum contagiosum occurs in approximately 10 to 20% of HIV-
infected persons.
83
 Early in the infection, the lesions are usually mild and 
localized to the groin or face. Once CD4 counts fall below 200, however, 
lesions tend to proliferate. They often number greater than 100 and may 
involve the face, trunk, and groin; there is a predilection for the eyelids.
99
 
Extensive molluscum contagiosum is a cutaneous marker of advanced HIV 
disease (CD4 < 50). At this stage, molluscum may extend onto mucosal 
surfaces of the lips or conjunctiva. Patients with advanced HIV disease are 
rarely cured of their molluscum. The finding of subclinical, microscopic 
infection in apparently normal skin may explain failure to cure patients.
100   
Giant mollusum contagiosum should make one to  suspect HIV disease. 
 
 
Hepatitis B Virus Infection 
 HBV is transmitted primarily through sexual contact and intra venous 
drug use, whereas perinatal and early childhood exposures are responsible 
for the majority of HBV transmission in high-prevalence countries. 
Although risk factors are similar, HBV is transmitted more efficiently than 
HIV. 
101, 102, 103
 Up to 90% of HIV-infected persons have at least one serum 
marker of previous exposure to HBV.
104, 105
 And approximately 10% have 
evidence of chronic hepatitis B.
106, 107, 108 
 
Hepatitis C Virus Infection 
There are about 150 million chronic hepatitis C virus (HCV) carriers 
throughout the world, with an estimated global prevalence of 3% (range 0.1-
5%).
 109
 Following exposure to HCV, approximately 85% of patients 
develop chronic infection.
110, 111
 Co infection with HCV in HIV-infected 
individuals is common, presumably due to the shared route of transmission 
of these viruses. The prevalence of HCV infection among all HIV-infected 
individuals can be as high as 40% but this prevalence varies substantially 
among different risk groups.
112
 The prevalence of HCV among intra venous 
drug users (IDUs) who are HIV infected is 50-90%.
113,114,115,116,117
 In a large 
cohort of 3,048 HIV-infected subjects from the EuroSIDA study, 33% were 
HCV antibody positive and more than 75% of IDUs in this population were 
coinfected.
118
 However, the prevalence of HCV in HIV-infected men who 
have sex with men (MSM) is similar to that observed in HIV-negative 
homosexual males at 4-8%.
115,119
 Although the rate of sexual transmission of 
HCV is low (<5%), this rate may be increased in the presence of HIV. 
116,120,121,122,123 
 
The rate of mother-to-infant transmission of HCV increases in the 
presence of HIV, presumably due to high levels of HCV viremia observed in 
co infected individual.
124, 125,126
 HIV co infection has been associated with a 
more rapid progression of liver disease as well as a higher prevalence of 
cirrhosis.
115, 127,128,129
 
 
BACTERIAL INFECTIONS 
Staphylococcal Infections   
 Staphylococcus aureus is the most common cutaneous bacterial 
infection in persons with HIV disease. Approximately 50% of HIV-infected 
persons are nasal carriers of S. aureus, explaining in part the high rate of 
infection.
130, 131
 Infection with S. aureus may occur before any other signs or 
symptoms of HIV infection. Morphologic patterns that may occur include: 
bullous impetigo, ecthyma, folliculitis, hidradenitis-like plaques, abscesses, 
cellulitis, and pyomyositis.
132
 
Bullous Impetigo 
 
 Bullous impetigo is common in hot, humid weather, presenting as 
very superficial blisters or erosions, most commonly seen in the groin or 
axilla. Because the blisters are flaccid, they are short-lived; often only 
erosions or yellow crusts are present. These lesions closely mimic cutaneous 
candidiasis.
133 
 
Ecthyma 
 Ecthyma is an eroded or superficially ulcerated lesion with an 
adherent crust. Under this crust is often a plane of purulent material teeming 
with staphylococci. Removal of this crust is necessary to treat the lesion 
topically. 
Folliculitis 
 Folliculitis due to S. aureus occurs most commonly in the hairy areas 
of the trunk, groin, axilla, or face, especially in men who shave. Follicular 
pustules are the primary lesion. Often the follicular lesions of the trunk are 
intensely pruritic and may be mistaken for other pruritic dermatoses, such as 
scabies.
133
 About 50% of HIV-infected persons with scabies have coexistent 
S. aureus folliculitis. Occasionally, follicular lesions extend more deeply, 
forming abscesses. Rarely, all follicles across several square centimeters are 
infected, forming a large, violaceous, hidradenitis-like plaque. The plaque 
may be studded with pustules and have deep tracts connecting infected 
follicles. These plaques may mimic Kaposi’s Sarcoma, but overlying 
pustules are quite unusual in KS. Rarely, abscess of the muscle 
(pyomyositis) may occur.
132, 133,134,135,136 
 
Mycobacterial infections   
The World Health Organization (WHO) estimates that Tuberculosis is 
the cause of death for 13% of persons with AIDS.
137
 Tuberculosis infection 
occurs when a susceptible person inhales droplet nuclei containing 
Mycobacterium tuberculosis organisms, generated when persons with 
pulmonary or laryngeal Tuberculosis disease cough, sneeze, shout, or sing 
138
. Persons with latent Tuberculosis infection are, by definition, 
asymptomatic. Among HIV-infected persons, the presentation of active TB 
disease is influenced by the degree of immunodeficiency. 
137,138
 
 
In addition, early after initiating ART in severely immunosuppressed 
patients, previously unrecognized subclinical TB can be unmasked by 
reconstitution of the immune system.
139,140
 In HIV-infected patients without 
pronounced immunodeficiency (e.g., CD4
+
 count >350 cells/µL), HIV-
related TB clinically resembles TB among HIV-uninfected persons. The 
majority of patients have disease limited to the lungs, and common chest 
radiographic manifestations include upper lobe fibronodular infiltrates with 
or without cavitation
141
. However, extrapulmonary disease is more common 
in HIV-infected persons than in HIV-uninfected persons, regardless of 
CD4+ counts, although clinical manifestations are not substantially different 
from those described in HIV-uninfected persons. TB must be ruled out in 
diseases of every organ 
142
, but especially those related to CNS or meningeal 
symptoms in which early TB treatment is essential to improve the 
outcome.
143, 144
  
In patients with CD4+ count <200 cells/µL, Tuberculosis can be a 
severe systemic disease with high fevers, rapid progression, and sepsis 
syndrome.
145
 
 
In patients with AIDS, however, it Mycobacterium avium complex 
(MAC) is one of the most common serious opportunistic infections (OIs). 
Among HIV-infected individuals, disseminated MAC historically has 
occurred almost exclusively in patients with a CD4 count <50 cells/µL.
146, 147
 
Colonization of the respiratory or gastrointestinal (GI) tract by MAC can 
occur without evident morbidity; however, MAC colonization of these sites 
indicates that patients are at increased risk for developing disseminated 
MAC infection.
148
 Combination antiretroviral therapy (ART) has been 
associated with reduction in AIDS-related mortality, days of hospitalization, 
and the incidence of new OIs.
149
 However, there have been numerous reports 
of aberrant clinical presentations of MAC since the introduction of 
combination ART.
150, 151,152,153,154,155 
 
Bacillary angiomatosis   
Bacillary angiomatosis (BA) is a disease characterized by unique 
vascular lesions caused by infection with small, gram-negative organisms of 
the genus Bartonella. Virtually all patients with this disease are infected 
with HIV1. A major challenge in the diagnosis of cutaneous BA is the 
diverse presentation of lesions.
156, 157
  Skin lesions may be classified as 
predominantly cutaneous or subcutaneous.
158
 Cutaneous lesions are often 
papular and red with a smooth or eroded 
surface,
159,160,161,162,163,164,165,166,157,167,168,169,170,171
 and papules may enlarge to 
form large, pedunculated lesions.
159,157,175
 These lesions have an obvious 
vascular appearance and an erythematous base and bleed profusely when 
traumatized. Other papular lesions and plaques may be dusky in colour, dry, 
scaly, and hyperkeratotic, with minimal clinical evidence of vascularity.
156
 
Cutaneous BA also may have the appearance of a cellulitic plaque; these 
cutaneous lesions often overlie osteolytic lesions.
156, 162
 Dark-skinned 
patients may develop an indurated, hyper pigmented plaque that may be 
nearly black.
176
 Cutaneous lesions may occur singly or number in the 
hundreds. 
157,159,164,175
 
 
Subcutaneous lesions may present as one or more deep nodules with 
flesh-colored
157
 or erythematous overlying skin.
176, 177
 Reports also describe 
presentation as a single, deep soft-tissue mass with normal-appearing 
overlying skin. 
156,178,179 
 
Lymphogranuloma venereum 
 Lymphogranuloma venereum (LGV) is caused by Chlamydia 
trachomatis serovars L1, L2, or L3.
180
 The most common clinical 
manifestation of LGV among heterosexuals is tender inguinal and/or femoral 
lymphadenopathy that is typically unilateral. This infection is found most 
frequently in tropical and subtropical areas of the world.
181
 The diagnosis is 
difficult to establish on clinical grounds alone and frequently relies upon 
either serologic testing, culture, or more recently, nucleic acid amplification 
testing of direct specimens.
182, 183 
 
Syphilis 
 Syphilis is the result of a bacterial infection of the genital tract by the 
bacterium Treponema pallidum. Most HIV-infected patients with T pallidum 
infection present with typical dermatologic clinical features of primary and 
secondary disease, such as chancres and diffuse maculopapular rashes.
184, 185, 
186, 187, 188 
  Syphilis can present in one of four different stages: primary, 
secondary, latent, and tertiary.
189
 Syphilis is associated with increased risk 
for HIV sexual acquisition and transmission.
190, 191 
Early syphilis in HIV-
infected persons may also cause a transient decrease in CD4+ count and 
increase in HIV viral load that improves with standard treatment 
regimens.
192, 193, 194 
 
Chancroid 
 Chancroid, caused by infection with Haemophilus ducreyi, is 
characterised by ano-genital ulceration and lymphadenitis with progression 
to bubo formation. The incubation period for this disease is short, around 3–
10 days, and the initial lesion is a papule that may progress to form an ulcer 
through an intermediate pustular stage.
197 
In fact, HIV has been detected in 
chancroidal ulcers.
195,196
  
 
PARASITIC INFECTIONS 
Scabies   
Scabies in HIV-infected persons usually presents with the typical 
pattern of pruritic papules with accentuation in the intertriginous areas, 
genitalia, and finger webs. With advancing immunosuppression, the 
infestation may exaggerate, becoming more widespread and refractory to 
treatment, and sparing the characteristic areas.
198
 In rare cases, true crusted 
(Norwegian) scabies may occur in patients with advanced HIV disease. 
Norwegian scabies is nonpruritic and appears as thick crusts over some areas 
of the body. These crusts teem with mites and are highly contagious.
199, 
200,201,202
 
 
Demodicidosis   
Mites such as Demodex folliculorum and D. Brevis  are natural host 
of the human pilosebaceous follicle and are responsible for skin disorders 
like  , papular and pustular eruptions of the scalp, acne rosacea etc. . The 
highest concentration of the demodex is found in the cutaneous areas with 
more numerous sebaceous glands. Demodicidosis in patients infected with 
HIV is already reported in the relevant literature both in adults and in 
children.
203
 
INFLAMMATORY DISODERS 
Seborrhoeic dermatitis 
Seborrhoeic dermatitis is a mild eruption, usually affecting the scalp 
and central areas of the face, which occurs in up to 5% of the non-HIV-
infected population. Early in the HIV epidemic, many patients with 
symptomatic HIV disease had particularly severe seborrheic dermatitis. One 
study found an 83% point prevalence of seborrheic dermatitis associated 
with advanced HIV disease and a 42% point prevalence with symptomatic 
HIV disease.
204 
 
Psoriasis 
The clinical appearance of psoriasis is similar in HIV-infected and no 
infected individuals. The incidence of severe involvement of the axillae and 
groin (sebopsoriasis), however, is increased in HIV-infected patients.
205
 In 
addition, psoriatic erythroderma is not rare in these patients.
206 
 As in routine 
psoriasis, pruritus may be a serious problem for the HIV-infected patient 
with psoriasis. With scratching, secondary infection of excoriated psoriatic 
plaques with S. aureus may occur. Erythrodermic psoriasis in HIV-infected 
patients may be a sign of S. aureus septicemia, and the psoriasis may 
improve dramatically with only intravenous antibiotics.
207
 
Reiter’s disease 
Classic Reiter's disease consists of the triad of arthritis, conjunctivitis, 
and urethritis.  Usually, symptoms of HIV infection and Reiter's disease 
appear simultaneously or the HIV infection is symptomatic before the onset 
of Reiter's disease. Patients may initially present, however, with classic 
cutaneous lesions of RS before manifesting clinical symptoms of HIV 
infection.
206, 208 
 
Ichthyosiform dermatoses 
HIV-infected patients commonly complain of increasing dryness of 
the skin (xerosis).
209,210 
Patients with an atopic diathesis (hay fever, asthma, 
or previous atopic dermatitis) are predisposed to this type of xerotic eczema. 
Dry and thickened skin, as is seen in acquired ichthyosis, is seen in patients 
with advanced HIV disease. Thickening of the palms and soles may be 
present as well.
211,212 
 
Papular and follicular eruption of HIV   
Pruritic Papular Eruptions 
Pruritic papules are common in HIV infection
213
 and are due to 
various causes. Reports describe S. aureus folliculitis, eosinophilic 
folliculitis, demodicidosis mites,
214
 insect bite reactions, and granulomas 
with no identifiable infectious agent (e.g., granuloma annulare
215
) as causes 
of itching in the setting of HIV. We think there is no specific and unique 
"papular eruption of HIV infection." Most patients with this diagnosis have 
eosinophilic folliculitis
216
. Rarely, pruritus with no primary skin lesions may 
be the presenting sign of HIV disease.
217 
 Eosinophilic Folliculitis of HIV Disease 
Bacteria do not cause all folliculitis in HIV-infected patients. Culture-
negative folliculitis commonly reveals eosinophils on biopsy.
218
 Cases in 
which the biopsy shows eosinophils within or around the follicle have been 
called eosinophilic folliculitis of HIV infection. This disorder typically 
occurs in HIV-infected persons with helper T cell counts below 200, so it is 
an important cutaneous marker of a specific stage of HIV disease. The 
eruption waxes and wanes. Intensely pruritic, edematous, urticarial papules 
and pustules appear in crops on the trunk or face or both. Cultures and 
histological examination for infectious agents are negative, but a relative 
peripheral eosinophilia may be present.
219, 220
  
 
Drug reaction 
Trimethoprim Sulfamethoxazole is used frequently in managing PCP. 
The incidence of adverse reactions to the drug is very high; Most reactions 
occur in the second week of therapy and are typical 
maculopapular/morbilliform reactions. They begin in the groin and pressure 
areas and quickly generalize.
221
 Other drug-induced hypersensitivity 
reactions in HIV-infected patients are urticarial reactions, exfoliative 
erythroderma, fixed-drug eruption, erythema multiforme, and toxic 
epidermal necrolysis. These reactions are most often due to antibiotics, 
especially TMP-SMZ and the penicillins. These reactions may take up to 8 
weeks to clear. Multiple sequential reactions are not unusual.
222
  
 
NEOPLASIA  
Kaposi’s sarcoma  
Kaposi’s sarcoma (KS) is a neoplasm of endothelial cells involving 
the skin and, at times, other internal organs. KS is common among HIV-
infected persons, but there is not an equal incidence in all risk groups. Most 
KS patients are homosexual men. In one series, 46% of homosexual men 
with advanced HIV disease had KS at the time of their initial diagnosis. The 
incidence in heterosexual injection drug users is only 3.8%.
223
 Several 
homosexual men have been identified who developed KS but who are 
uninfected with HIV by all current testing methods.
224
 These data support 
the involvement of a sexually transmitted infectious agent. Herpes virus 8 
(HHV-8) has been associated with KS.
225, 226,227,228,229,230,231
 
KS may affect any portion of the cutaneous surface. Initially, it 
appears as red-to-brown flat macules. Papules, nodules, and tumors may also 
be present or develop later. KS may affect mucosal surfaces and internal 
organs with or without involving the skin. Visceral involvement occurs in 
72% of patients with advanced HIV disease and KS, most often affecting the 
gastrointestinal tract (50%), lymph nodes (50%), and lungs (37%).
232
 The 
natural history of HIV-associated KS is not uniform, but the prognosis is 
poor. The average survival of patients is 18 months.
232
 Most individuals 
have generalized, slowly progressive disease; others have stable KS. Even 
more rarely, the disease may resolve spontaneously.
233
 Poor prognostic 
findings include generalized disease and coexistent opportunistic infections; 
the latter are the most common cause of death.
232
 
Lymphoma  
HIV-1-associated lymphoma was first incorporated into the U.S. 
Centers for Disease Control and Prevention's (CDC) case definition of AIDS 
in 1985.
234,235
 Without effective antiretroviral therapy, it is estimated that 5-
10% of all HIV-infected individuals will have lymphoma as either an initial 
or subsequent AIDS-defining condition.
236
 A 1991 review
237
 of 2,500 cases 
of HIV-1-associated lymphomas revealed that approximately 80% arose in 
the periphery (i.e., "systemic" lymphomas), and 20% arose in the central 
nervous system (CNS).
238,239,240
 For HIV-1-associated systemic lymphomas, 
widespread disease involving extranodal sites is common.
241, 242,243
 
Other cutaneous carcinomas 
Other cutaneous carcinomas are not unusual in HIV-infected patients. 
Fair-skinned patients with significant prior sun exposure are at risk for basal 
cell carcinomas (BCCs) and squamous cell carcinomas.
244, 245,246
 BCCs 
commonly present on the back or chest as nonhealing scaly patches that may 
erode or bleed. Squamous cell carcinomas are associated with more sun 
exposure and are more common on the head and neck. Occasionally, HIV-
associated lymphoma of either T or B cells will present in the skin.
246, 
247,248,249
 
 
MISCELLENEOUS DERMATOSES 
Hidradenitis suppurativa 
Hidradenitis suppurativa (HS) is a disorder of the terminal follicular 
epithelium in the apocrine gland-bearing skin. It is characterized by comedo-
like follicular occlusion, chronic relapsing inflammation, mucopurulent 
discharge, and progressive scarring.
250
 The disease begins with the 
obstruction of the apocrine gland duct, resulting in the infection of the 
retained secretions.
251
 Atypical sites were involved in HIV patients such as 
face, thighs which could be due to HIV-related immunosuppression. 
Etiology may also have an endocrinal component, and HIV-associated 
endocrinopathies may alter the course of the disease. Association of AIDS 
with a chronic skin condition like HS is a therapeutic challenge.
252 
 
Generalised hyper pigmentation 
Generalised hyper pigmentation and addisonian pigmentation, 
apparently independent of drug therapy have been reported in AIDS patients 
in southeast Asia.
253,254
 Numerous factors are responsible, including drugs 
for treatment and prophylaxis, endocrine disturbances caused by HI, sun 
exposure and OIs.
253 
 
Insect bite reactions --- increased  
Urticarial pruritic papules are a common morphologic lesion in HIV-
infected patients. In occasional patients, this lesion is associated with insect 
bites and is called papular urticaria. In HIV-infected patients in San 
Francisco, except for scabies mites, fleas most commonly cause papular 
urticaria. In the southern United States, mosquitoes may be the primary 
offender.
255, 256 
 
Photosensitive eruptions 
Reports rarely describe photosensitivity in HIV-infected persons.
257
 
Such reactions are not unusual, however. Erythematous patches and plaques 
appear during periods of increased sun exposure, primarily on exposed body 
parts, especially the dorsa of the hands, extensor forearms, side of the neck, 
and face. The photosensitivity is usually due to the shorter ultraviolet 
spectrum (UVB). Frequently prescribed photosensitizing medications 
(nonsteroidal anti-inflammatory drugs and TMP-SMZ) used in HIV-infected 
patients may play a role in their photosensitivity.
88 
 
HAIR CHANGES 
Severe tinea capitis with significant hair loss has been reported in 
several adult patients with AIDS
258,259
.Changes in hair length and 
consistency
260,261
, hypertrichosis of eyelashes and very long 
eyelashes
262,263
,alopecia areata
264,265
 and premature graying of the hair
266,267
 
have been reported in association with HIV infection. 
 
NAIL CHANGES 
Diseases of the nail may be observed in up to32% of patients.
259
 
Proximal subungual onychomycosis appear to be related to the effect of HIV 
infection on immune system.
259, 268 
Others such as nail dyschromia are the 
result of antiretroviral therapy.
259
 
MAJOR MUCOCUTANEOUS FINDINGS IN INDIAN STUDIES 
 Criton et al studied the various mucocutaneous manifestations in HIV 
patients and found out that Generalised itching and dry skin is the 
commonest one followed by in order of frequency Lustreless hair, Hyper 
pigmented nail bed, Acne vulgaris, Oral candidiasis, Hyper pigmentation, 
Seborrhoea like lesions, Exaggerated insect bite reaction, Dermatophytosis 
and Viral infections.
269
 
 
Muhlemann et al  studied the various  dermatological manifestations 
in HIV patients  and  found out that Extensive fungal infection is the  most 
common, followed by Acneiform folliculitis, Seborrhoeic dermatitis, 
Axillary folliculitis, Kaposi’s sarcoma, Xeroderma and Beard and neck 
impetigo. They concluded that chronic acneiform folliculitis, florid Beard 
and neck impetigo and fungal infections are early warning signs of AIDS.
270
 
 
Goodman et al studied the various dermatological manifestations in 
HIV patients and found out that Candidiasis is the commonest one. The 
other manifestations are recorded in decreasing order Seborrhoeic dermatitis, 
Dermatophytosis, Xerosis/acquired ichthyosis, Herpes simplex, Molluscum 
contagiosum, Verrucae, Acne, Kaposi’s sarcoma and Herpes zoster. They 
concluded that skin is the early and sensitive marker for the presence of 
clinically apparent HIV infecton.
271
 
Matis et al studied the various mucocutaneous manifestations in HIV 
patients and found out that Onychomycosis is the commonest one followed 
by Seborrhoeic dermatitis, Oral hairy leukoplakia, Condyloma accuminata, 
Oral candidiasis, Herpes simplex, Molluscum contagiosum and Verruca 
vulgaris in decreasing order of frequency.
272 
 
Valle studied the various dermatological manifestations in HIV 
patients and found out that Oral candidiasis is the commonest one, followed 
by Seborrhoeic dermatitis, Tinea interdigitale, Asteatosis, Infective 
eczematoid dermatitis, Warts, Acquired Ichthyosis and Herpes simplex. 
They found out that gradual worsening of seborrheic dermatitis paralleled 
the deterioration of the clinical condition and the development of acquired 
ichthyosis and gradual worsening of asteatosis was related to progression 
from ARC to AIDS.
273 
 
Alesi  et al studied the various  mucocutaneous manifestations in HIV 
patients  and  found out that Seborrhoeic dermatitis  is the commonest one, 
followed by Herpes simplex, Warts/ Condyloma accuminata, Oral hairy 
leukoplakia, Oral candidiasis,Folliculitis, Dermatophytosis, Kaposi’s 
sarcoma and Herpes zoster in decreasing order of frequency. They 
concluded that Oral candidiasis and Herpes zoster are signs of transition to 
AIDS and Kaposi’s sarcoma chronic Herpes simplex are classic signs of 
fully developed AIDS.
274
 
Kar et al studied the various mucocutaneous manifestations in HIV 
patients and found out that Oral thrush followed by Herpes zoster, 
Seborrhoeic dermatitis, Monilial balanoposthitis, Eosinophilic folliculitis 
and Dryness of the skin in decreasing order of frequency. They concluded 
that fungal or viral infections were the largest category of cutaneous 
disorders associated with HIV infection.
275 
 
Kumarasamy et al studied the various mucocutaneous manifestations 
in HIV patients and found out that Oral candidiasis is the commonest 
finding. Other findings in the decreasing order of frequency are 
Multidermatomal Herpes zoster, Dermatophytosis, Genital herpes, Papular 
pruritic dermatitis, Staphylococcal infection, Oral hairy leukoplakia, 
Molluscum contagiosum, Genital warts and Scabies.
276 
 
Jindal et al studied the various  mucocutaneous manifestations in HIV 
patients  and  found out that  Herpes zoster  is the commonest one, followed 
by Mucocutaneous candidiasis, Dermatophytosis, Molluscum contagiosum, 
Scabies, Pyoderma, Venereal warts, Genital herpes, Chancroid, Candidal 
balanoposthitis, Herpes labialis, Seborrhoeic dermatitis  ,Pruritic papular 
eruptions, Mucosal lichen planus, Miliaria rubra, Lichen simplex chronicus 
and Drug rash.
277 
  
 
 
 
 
 
 
 
 
Aim of the Study 
AIM OF THE STUDY 
 
1. To collect data and analyze the dermatological presentations in HIV 
patients. 
 
2. If the patients were on antiretroviral therapy to assess the frequency of 
specific dermatological diseases or adverse reactions to antiretroviral 
drugs. 
 
3. To assess the common dermatological diseases in HIV patients. 
 
4. To correlate the CD4+ count at which usually each dermatological 
disease will occur. 
            
  
 
 
 
 
 
 
 
 
Materials & Methods            
MATERIALS AND METHODS 
         
The study was conducted in Department of Dermatology, 
Venereology and Leprology, Coimbatore Medical College Hospital during 
the period May2009 to April 2010. All the patients attending the 
Dermatology outpatient department at Coimbatore Medical College Hospital 
were screened and HIV patients with Mucocutaneous manifestations were 
enrolled.  
 
Inclusion criteria: 
                    All HIV patients attending the Skin and Venereology 
Department in Coimbatore medical college, age in between 18-55 years. 
 
Exclusion criteria: 
1. Patients less than 18 years and more than 55 years. 
2. Pregnant woman. 
All the HIV patients with mucocutaneous manifestations were 
enrolled in a chronological order. For each patient name, age, sex, address, 
occupation and income etc noted. Complaints, duration, history of 
recurrences, history suggestive of risk to sexually transmitted infections, past 
history, family history and treatment history were also noted. 
A thorough examination of both general and systemic carried out. 
Dermatological examination including the number, site, morphology and 
distribution of primary and secondary lesions then examination of oral and 
genital mucosa, scalp, hair, nail, palms and soles carried out. Based on this 
patients were classified as having infective, inflammatory, neoplastic and 
other diseases. 
 
Investigations like haemogram, blood sugar, blood VDRL, liver 
function test, urine examination, Mantoux test and CD4 count were done in 
all cases. Scraping for fungus, appropriate staining and biopsy were done in 
relevant cases. 
 
              All the patients were given symptomatic treatment. Details thus 
obtained were compiled, tabulated and statistically summarized. 
 
  
 
 
 
 
 
 
 
 
 
Observations and Results 
OBSERVATIONS AND RESULTS 
After analyzing 100 HIV patients with mucocutaneous manifestations 
the following observations were made. 
Sex incidence 
 
 
 
 
Graphical Representation of Sex Incidence: 
 
Out of 100 cases studied 57(57%) were males and 47(47%) were 
females. This indicates a male preponderance. 
 
Sex Frequency Percent 
Female 47 47 
Male 53 53 
Total 100 100 
Age incidence 
Age No. of  Persons Percentage 
18-25 6 6 
25-32 24 24 
32-39 34 34 
39-46 27 27 
46-53 9 9 
Total 100 100 
 
Graphical representation of Age incidence 
 
            Maximum incidence was noted in the age group between 32-39 years 
(34%).Minimum incidence was noted in the age group between 18-25 years 
(6%). 
 
Incidence in Occupation 
Occupation No. of  Persons Percentage 
Unskilled 42 42 
Skilled 38 38 
House wife 20 20 
Total 100 100 
 
Graphical representation of Various Occupation 
 
Out of the 100 cases studied, 42 (42%) were unskilled workers, 
38(38%) were skilled workers and 20(20%) were house wife. Maximum 
incidence was observed in unskilled workers. 
Risk to STD 
Category Frequency Percentage 
PMC & EMC 32 32 
EMC 18 18 
Blood transfusion 13 13 
Promiscuous 13 13 
PMC 10 10 
First husband 2 2 
Homo sexual 1 1 
I V drug 1 1 
Denies 10 10 
Total 100 100 
 
 
Graphical Representation for risk to STD 
 
In 100 Patients observed 2% had received HIV from their first 
husband, 13% received infection  through blood transfusion, 10% of them 
deny the fact that they had extra marital or premarital contact, 18% had extra 
marital contact, 1% had homosexual contact, 1% had Intravenous drug use, 
10% had premarital contact, 32% had premarital contact and extra marital 
contact and 13% were promiscuous individuals. 
Skin Diseases in HIV Infected Patients 
Viral Infection 
Skin Disease Frequency Percentage 
HZ 13 13 
H.Simplex 8 8 
Verrruca Vulgaris 4 4 
M.C 4 4 
Chicken Pox 1 1 
OHL 1 1 
PR 1 1 
Fungal Infection 
Dermatophyte  8 8 
Candidiasis 7 7 
T.V 1 1 
Bacterial Infection 
Abscess 2 2 
Folliculitis 1 1 
Hansen's Disease  2 2 
Parasitic Infection 
Scabies 1 1 
Inflammatory Conditions 
PPE 24 24 
Psoriasis 3 3 
Xerosis 4 4 
Eczema 1 1 
Nevirapine Rash 1 1 
Miscellaneous 
Hidradenitis 
Suppurativa 
2 2 
Aphthous Ulcer 1 1 
Pompholyx 1 1 
PSE 2 2 
AV 2 2 
LP 2 2 
Vitiligo 1 1 
Nail Changes 
Long Melanonychia 2 2 
 
Graphical Representation for Skin Disease In HIV Infected Patients 
 
 
Out of the 100 cases studied Herpes zoster (13%) is the most common 
infectious disease and pruritic popular eruption (24%) is the most common 
non-infectious condition. 
In 100 cases 13 cases were Herpes zoster (13%). Of which 8 cases 
were multidermatomal Herpes zoster. One case was associated with 
psoriasis. Next common viral infection is Herpes simplex, 8 cases (8%).Of 
which genital Herpes simplex was 5 cases and oral Herpes simplex was 3 
cases. Extensive genital herpes was seen in 2 cases. There were 4 cases (4%) 
of Verruca vulgaris and 4 cases (4%) of Molluscum contagiosum. One case 
of Molluscum contagiosum was associated with plane wart. One case (1%) 
was Oral hairy leukoplakia (OHL). There was one case (1%) of chicken pox. 
There was also one case (1%) of Pityriasis rosea. 
 
 Fungal infections are the next common infectious disease. Out of 
the 100 cases 8(8%) were Dematophytic infection. There were 5 cases of 
Tinea corporis, 2 cases of Tinea unguium and one case of Tinea cruris. 
Candidiasis is the next common fungal infection. There were 7 cases (7%) of 
candidiasis. There were 4 of cases oral candidiasis, 2 cases of vulvo vaginal 
candidiasis and one case of oesophageal candidiasis. There was one case 
(1%) of Tinea versicolor. 
 
 Bacterial infections are the 3
rd
 common infectious disease, 5 cases 
(5%). There were 2 cases of multiple skin abscess and one case of 
folliculitis. Also there were 2 cases of Hansen’s disease, one case was 
Borderline Tuberculoid with type 1 lepra reaction and the other was Histoid 
Hansen. 
 
             Out of 100 cases there was only one case (1%) of scabies. 
             The most common skin condition is Pruritic papular eruption (PPE). 
There were 24 cases (24%) of Pruritic papular eruption. Out of this one case 
was associated with candidal intertrigo .  Pruritic papular eruption was 
associated with oral candidiasis and seborrheic dermatitis in one case. There 
was one case associated with Tinea barbae. One was associated with OHL, 
one with photosensitive eczema, one with melanonychia, one with melasma 
and one case with both melasma and melanonychia. 
 
           There were 4 cases (4%) of Xerosis. One was associated with 
asteatotic eczema and other one was with seborrheic dermatitis. There were 
3 cases (3%) of Psoriasis. One case was associated with angular chelitis. 
There were 2 cases of photosensitive eczema and one case of Pompholyx 
with Melasma. There was one case of Aphthous ulcer, one case of Eczema 
and one case of Nevirapine rash. 
 
             In miscellaneous conditions there were 2 cases (2%) of Hidradenitis 
suppurativa. Other conditions were 2 cases (2%) of Acne vulgaris, 2 cases of 
Lichen planus and one case of vitiligo.
PAST HISTORY 
 
Disease Frequency Percent 
pulmonary TB 21 21 
TB adinitis 2 2 
DM 1 1 
Typhoid 1 1 
leprosy 1 1 
HTN 1 1 
None 73 73 
Total 100 100 
 
Graphical Representation of Past history 
 
 Out of the 100 cases 21(21%) had history of Pulmonary 
Tuberculosis. Two patients had history of tuberculous cervical 
lymphadenitis. One has Diabetes mellitus and one has Hypertension. History 
of Typhoid fever was recorded in one patient and one had history of 
Leprosy. Out of 100 73 cases (73%) had no history of any significant disease 
in past. 
Treatment History 
Category Frequency Percent 
ART 67 67 
Not On ART 33 33 
Total 100 100 
 
Graphical Representation for Treatment History: 
 
Out of the 100 patients 67(67%) was on ART and 33(33%) was not on ART. 
Family history 
 
Family Details 
Frequency Percent 
Spouse +ve 47 47 
Spouse & children +ve 11 11 
Spouse & children -ve 28 28 
Children +ve 2 2 
Unmarried 9 9 
unknown 3 3 
Total 100 100 
 
Graphical Representation for Family History 
 
        Out of the 100 patients spouse was HIV reactive in 47cases (47%). In 
11 cases (11%) both spouse and children were HIV reactive. Only children 
were positive in 2 cases. Out of this 9 patients (9%) were unmarried. Both 
spouse and children were HIV nonreactive in 28 cases (28%).The status was 
unknown in 3 cases (3%). 
General Examination  
Examination Frequency Percent 
Normal 75 75 
Pallor 25 25 
Total 100 100 
 
Graphical Representation for General Examination   
 
 
 Out of these 100 cases pallor was observed in 25 patients (25%).No 
abnormality in general examination in 75 patients (75%). 
Systemic examination 
          Systemic examination was normal in all patients. 
Investigations 
1. Complete haemogram: 25 patients had anaemia. 
2. Blood sugar: normal in all patients 
3. Blood VDRL: Non Reactive in all patients. 
4. Liver function test: One patient had elevated bilirubin, SGOT, 
SGPT and ALP values. 
5. Urine examination: Normal in all patients. 
6. MantouxTest: Negative in all patients. 
7. CD4+ count was done by flowcytometry in all HIV positives. 
Tabular representation of CD4+ count:      
CD4+ count No. of  Persons Percentage 
<100 12 12 
100-200 27 27 
201-350 33 33 
351-500 17 17 
>500 11 11 
Total 100 100 
 
 
 
8. Scraping for fungus: Pseudo hyphae were seen in 7 cases. Hyalinised 
septate branching hyphae with spores were seen in 11 cases. 
9. Staining: Multinucleated giant cells were seen in17 cases. Molluscum 
bodies were observed in 4 cases. AFB staining for Mycobacterium 
leprae was positive in 1 case. Gram positive cocci were seen in 4 
cases. 
10. Biopsy: Biopsy was done in 9 cases. 3cases were psoriasis.2 case 
were Lichen planus. One case was Histoid Hansen. One case was 
Borderline tuberculoid Leprosy with type 1 lepra reaction. One case 
was Verruca vulgaris and one was Verruca plana. 
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Discussion  
DISCUSSION 
In our study maximum incidence of cutaneous manifestation was 
noted in the age group between 32- 39(34%). This is similar to that reported 
in literature.
277
 From our analysis we noted a male predominance in HIV 
population. Jindal N, et al. quoted a female predominance in cutaneous 
manifestations.
277
 We observed a higher ratio of HIV infection in unskilled 
workers. This may be due to Coimbatore being an industrial area were 
migrant population is high. It was observed that most of the seropositive 
men had acquired the infection from commercial sex workers and had 
passed it on to their spouse through unprotected sexual intercourse. 91% 
infected person were married in this observation. Heterosexual 
transmission(75%) was the highest mode of transmission in our analysis, 
similar to other studies.
277,278 
We also noted that HIV transmission through 
infected blood transfusion(13%) was somewhat low in our population 
compared to other study.
279
 A good number of the patients (67%) were 
registered for Anti retroviral Therapy in our case study. 
Because of immunosuppression, HIV positive patients have various 
cutaneous manifestations expected than others.  In this analysis multiple 
lesions were observed in 16% of patients, this is to some extent less 
compared to other study.
277
  In most of our patients the etiology was non 
infectious and the most common lesion was Pruritic papular eruption (24%). 
This is in concurrence with the findings of Ajay S et al .
280
  Next to Pruritic 
papular eruption  the maximum etiology was viral infection mainly Herpes 
zoster (13%) of which 8 patients had multi dermatomal Herpes zoster similar 
to other study.
277
 Its is important to recognize the  wide and varied spectrum 
of Herpes zoster in HIV patients. In our analysis we had 8% of the patients 
with Herpes Simplex and 8% had Dermatophyte infection, our observation 
was similar to that of Kumarasamy et al
276
 and Spira et al.
280 
As most of the 
patient on ART the mucocutaneous Candidiasis was observed in 7% 
compared to Singh. H et al
281
 study. Extensive Molluscum contagiosum was 
the manifestation of 4% of patients. This is low compared to the 
observations of Jindal. N.et al (13%).
 277
  We observed that 4% of patients 
had common wart, Compared to other studies
276,277
 there was no case of 
Genital wart in this analysis. 
 
In our analysis 4% patients had Xerosis, this may be due to the disease 
itself or due to chronic malnutrition. India is a developing country and 
malnutrition is a common problem, this value is somewhat less compared to 
other Indian studies.
271, 278
 We also found out that 3% of patients had 
Psoriasis. 
 
Although the prevalence of leprosy is falling in India, its recognition, 
especially tuberculoid leprosy, and diagnosis is important in the 
management of Immune Reconstitution Inflammatory syndrome (IRIS).
 282
 
The disease was not so uncommon in our place. We detected 2 cases of 
Hansen’s disease. One case was presented as Immune Reconstitution 
Inflammatory syndrome (IRIS), after one month of ART. Previously 
undetected leprosy has been diagnosed after onset of IRIS in HIV patients.
 
283, 284 
It was a case of Borderline Tuberculoid  Leprosy with type 1 lepra 
reaction. The other case was Histoid  Hansen. 
 
We observed 2 cases of Hidradenitis suppurativa which is less 
compared to Nair SP et al study.
285
 Although most of our study patients were 
on ART only 2 patients had longitudinal melanonychia.  Sharma A et al 
reported 14% of patients with nail pigmentation.
286 
Other condition observed 
in the present study were Oral hairy leukoplakia (1%) which is not as 
common as reported by Nair SP et al
285
 may due to the fact that most of the 
patients were on ART. There were 2 cases of skin abscess and one case of 
folliculitis, this was less compared to study by Bhandary P G, et al.
287  
There 
was one case of Nevirapine rash ,this was low compared to other study.
286  
There was one case of scabies. Jindal N, et al. was observed 4 patients (10%) 
with scabies.
277 
There were 2 cases of Lichen planus, this was correlating 
with other study.
277
 There were 2 cases of Seborrheic dermatitis, this was 
less compared to an earlier study.
287
 Other conditions observed in our study 
were Aphthous ulcer, Pompholyx, Photosensitive eczema, Pityriasis rosea, 
Acne vulgaris, Chicken pox, Eczema, and Vitiligo. No case of cutaneous  
Neoplasia was observed. 
 Majority of skin disease was observed when the CD4+ count falls 
below 350. There were 33 patients with CD4+ count 201-350 and 27 
patients with CD4+ 100-200. In patients with Pruritic Papular Eruption the 
CD4+ count was in the range of 68-280. In case of Herpes zoster the range 
of the CD4+ count was 46-493. Dermatophyte infection was seen in the 
range of 89-658. In Candidiasis the CD4+ count was low in most of the 
patients in the range of 80-335.In most of the patients with Herpes simplex 
there was low CD4+ count. Oral hairy leukoplakia was seen in the range of 
64-180. This was comparable with the study by Shobhana A.et al.
8 
There 
were 25% of patients with anemia, similar to other study.
286 
  
 
 
 
 
 
 
 
 
 
Conclusion           
CONCLUSION 
HIV/AIDS involves almost all the organs in the body. Mostly 
Infections and Malignancies are seen. Many a time the evolution of the 
cutaneous manifestation gives a clue to the diagnosis of HIV and stage of the 
disease. At times depending upon the CD4+ count, there is specific 
dermatological manifestations. Mostly cutaneous manifestations are clear 
markers of HIV disease, and many a time they may be the first lesion to be 
identified in an otherwise normal HIV reactive patient. 
 
In the present study we have attempted to identify the common 
cutaneous markers of HIV/AIDS and we have found out that indeed there is 
a correlation between certain dermatological conditions and HIV spectrum. 
Various previous studies and our study are correlating each other. Most 
common presentation in our study is Pruritic Papular Eruption(24%).Then 
Herpes Zoster(13%), Herpes simplex(8%), Dermatophytosis(8%) and 
Candidiasis(7%) was observed. Incidence of Candidiasis was probably low 
because patients were coming in the earlier stage  or had taken symptomatic 
treatment from outside. 
 
To conclude cutaneous manifestations are the most common 
presentation of HIV disease and Pruritic Papular Eruption, and Herpes 
Zoster are the tell tale evidences of HIV disease. 
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PROFORMA 
 
OP No:    DATE:   
 
Name : 
 
Age : 
 
Sex : 
 
Address : 
 
Occupation : 
 
Income: 
 
Complaints :    Duration: 
 
 
 1. 
 
 2. 
 
 3. 
 
History of Sexual exposure /Risk to STD 
 
Present History: 
 
 Evolution and spread of lesion 
 H/o recurrence 
 H/o Mucosal involvement 
 H/o prior drug intake 
 H/o fever/ weight loss/ diarrhoea 
 H/o altered taste/ dysphagia 
 
 
 
 
  
Past History: 
 
 
Family history: 
 
 Similar illness in family 
 
 
Treatment history: 
 
 
Personal history: 
 
 
General examination: 
 
 
 
Systemic examination: 
 
 
 
Dermatological examination: 
 
 
Skin: 
  Type of lesion 
   
Distribution     
 
Mucosa: 
 Oral       
 
 Genital 
 
                   Scalp: 
 
 
Hair and nail: 
 
 
Palms and Soles: 
 
 
 
  
 
SKIN DISEASES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Infective 
 
 
 
 
Bacterial 
Bacterial folliculitis  
Boil  
Impetigo  
Skin abscess  
Syphilis(1⁰ & 2⁰)  
Tuberculosis  
Atypical mycobacterium  
Bacillary angiomatosis   
  
  
  
 
 
 
Fungal 
Dermatophytosis  
Pityriasis versicolor  
Candidiasis  
Cryptococcosis  
Penicilliosis  
  
  
  
 
 
Viral 
Herpes Zoster  
Herpes Simplex  
Molluscum Contagiosum  
Wart  
  
  
 
Arthropod 
Scabies  
  
  
 
 
 
 
Inflammatory 
Cutaneous drug eruption  
Eosinophilic folliculitis  
Seborrhoeic dermatitis  
Psoriasis  
Atopic eczema  
Xerosis,icthyosis and asteatotic dermatitis  
Pruritic papular eruption  
  
  
 
 
\Neoplastic 
Kaposi’s sarcoma  
Non-Hodgkin’s Lymphoma  
  
  
  
 
Miscellaneous 
Lipodystrophy syndrome  
Conditions involving nails and hairs  
  
INVESTIGATION 
Blood: 
 Hb 
 
 TC 
 
 DC 
 
 ESR 
 
 Platelet count 
 
 
Blood VDRL : 
 
LFT  : 
 Billirubin... Total: 
  Direct: 
 SGOT : 
 SGPT : 
 ALP : 
 Sr Albumin : 
     Globulin : 
   
Urine Examination : 
 
 
 
 
Mantoux Test :  
 
CD4 Count  : 
 
Scraping for Fungus : 
 
Staining                       : 
 
Biopsy  : 
 
 
Culture  : 
 
 
Follow up: 
ABBREVIATIONS 
 
AIDS   Acquired immunodeficiency syndrome 
HIV   Human immunodeficiency virus 
KS   Kaposi’s sarcoma 
ART   Anti retroviral therapy 
IDU   Intra venous drug use 
STD   Sexually transmitted disease 
ARV   Antiretroviral drugs 
MTCT  Mother to child transmission 
RT PCR  Reverse transcriptase polymerase chain reaction 
CD   Cluster differentiation 
OHL   Oral hairy leukoplakia 
MAC   Mycobacterium avium complex 
CMV   Cytomegalovirus  
PCP   Pneumocystis carinii pneumonia 
OPC   Oropharyngeal candidiasis 
HSV   Herpes simplex virus 
EBV   Epstein barr virus 
VZV   Varicella zoster virus 
HPV   Human papilloma virus 
HBV   Hepatitis B virus 
HCV   Hepatitis C virus 
TB   Tuberculosis 
BA   Bacillary angiomatosis 
OI   Opportunistic infection 
HS   Hydradenitis suppurativa 
MC   Molluscum contagiosum 
PR   Pityriasis rosea 
HZ   Herpes zoster 
TV   Tinea versicolor 
PPE   Pruritic papular eruption 
PSE   Photo sensitive eczema 
AV   Acne vulgaris 
LP   Lichen planus 
DM   Diabetes mellitus 
HTN   Hypertension  
IRIS   Immune reconstitution inflammatory syndrome 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Master Chart
 

KEY TO THE MASTER CHART 
 
UNSK  Unskilled workers 
SK  Skilled workers 
HW  House wife 
EMC  Extra marital contact 
MSM  Male having sex with male 
PTB  Pulmonary Tuberculosis 
R  HIV reactive 
NR  HIV nonreactive 
UNM  Unmarried 
Unkn  Unknown HIV status 
P+     Pallor present 
UL  Upper limb 
LL  Lower limb 
T.barbae Tinea barbae 
T. corporis Tinea corporis 
M  Male 
F  Female 
CBE  Coimbatore 
POL  Pollachi 
TIR  Thirpur 
ANR  Annoor 
SLM  Salem 
KUR  Karur 
ERD  Erode 
PKD  Palakad 
CNR  Coonoor 
PM  Promiscuous 
BT  Blood Transfusion 
TYPH   Typhoid 
TBLN  Tuberculous Lymphadenitis 
HD  Hansen’s Disease 
N  Normal 
VVC  Vulvo Vaginal Candidiasis 
LM  Longitudinal Melanonychia 
HPG  Hyper pigmentation 
ITR  Intertrigo 
DPIG  Depigmentation 
Bor Tub Borderline Tuberculoid 
 
 
                                                                        
           
 
